🇺🇸 FDA
Patent

US 8481760

Inhibition and treatment of prostate cancer metastasis

granted A61KA61K31/37A61P

Quick answer

US patent 8481760 (Inhibition and treatment of prostate cancer metastasis) held by Northwestern University expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/37, A61P, A61P35/00